• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Article

Immune system and melanoma

National report - Two teams of U.S. researchers have been able to manipulate immune cells to apparently stop skin cancer from progressing, according to News-Medical.net.

National report - Two teams of U.S. researchers have been able to manipulate immune cells to apparently stop skin cancer from progressing, according to News-Medical.net/.

One study found it possible to suppress the Tregs cell, which controls the number of T cells, by blocking the activity of a protein on the cell's surface, leaving other parts of the immune system free to attack.

A second study found that when patients with advanced melanoma were given a drug combination of the diphtheria toxin and interleukin 2 to knock out T-regulatory cells, tumors shrank or remained stable in five of seven patients. All seven remained alive 12 months after treatment.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.